ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 24 of 34 for:    "Diabetic Ketoacidosis"

Evaluation of the Cerebral Edema in Children Having Diabetic Ketoacidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02937441
Recruitment Status : Recruiting
First Posted : October 18, 2016
Last Update Posted : October 19, 2016
Sponsor:
Information provided by (Responsible Party):
Ozlem Tolu Kendir, Cukurova University

Brief Summary:
The purpose of this study is to determine cerebral edema with evaluation of measurement of diameter of optic nerve sheath.

Condition or disease Intervention/treatment
Cerebral Edema Other: Ultrasonic Measurement

Detailed Description:

The purpose of this study is to determine cerebral edema with evaluation of measurement of diameter of optic nerve sheath. For that, If patients have Fluid treatment shall be started in 4 hours in our or other Emergency Care, they will be included our study. If not, they will be out of our study.

How we measure;

  1. First measurement shall be taken in 4 hours.
  2. Second measurement shall be taken at 12 hours in mild and 12-18 hours measurement shall be taken for severe diabetic ketoacidosis,
  3. Third measurement shall be taken after fluid treatment.
  4. Fourth measurement shall be taken at polyclinic control. So, after all measurements will be hand and all data will be analyzed with statistical program. After that all outcome will be discussed and compared with patient at normal conditions at their polyclinic visit.

Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Cerebral Edema With Measurement of Optic Nerve Sheath in Children Having Diabetic Ketoacidosis
Study Start Date : August 2016
Estimated Primary Completion Date : March 2017
Estimated Study Completion Date : June 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Edema


Intervention Details:
  • Other: Ultrasonic Measurement

    How we measure;

    1. First measurement shall be taken in 4 hours.
    2. Second measurement shall be taken at 12 hours in mild and 12-18 hours measurement shall be taken for severe diabetic ketoacidosis,
    3. Third measurement shall be taken after fluid treatment.
    4. Fourth measurement shall be taken at patients polyclinic control.


Primary Outcome Measures :
  1. Optic Nerve Sheath diameters will be measured from 3 mm back of globe. [ Time Frame: March 2017 ]
    Optic Nerve Sheath diameters will be measured in Children Having Diabetic Ketoacidosis and compared with normal conditions at polyclinic.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Month to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
General
Criteria

Inclusion Criteria:

Fluid treatment shall be started in 4 hours in our or other Emergency Care

Exclusion Criteria:

Fluid treatment was started over four hours in other Emergency Care


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02937441


Contacts
Contact: Özlem T Kendir, Dr. Fellow +905053049809 otolu80@yahoo.com

Locations
Turkey
Cukurova University Recruiting
Adana, Turkey
Sponsors and Collaborators
Cukurova University
Investigators
Principal Investigator: Özlem T Kendir, Dr. Fellow Cukurova University

Responsible Party: Ozlem Tolu Kendir, Fellow, Cukurova University
ClinicalTrials.gov Identifier: NCT02937441     History of Changes
Other Study ID Numbers: CUTF-GOKAEK-55-38
First Posted: October 18, 2016    Key Record Dates
Last Update Posted: October 19, 2016
Last Verified: October 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Keywords provided by Ozlem Tolu Kendir, Cukurova University:
C10.228.140.187

Additional relevant MeSH terms:
Diabetic Ketoacidosis
Edema
Ketosis
Brain Edema
Signs and Symptoms
Acidosis
Acid-Base Imbalance
Metabolic Diseases
Diabetes Mellitus
Glucose Metabolism Disorders
Diabetes Complications
Endocrine System Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases